Heighten Science Publications Inc.

How Hospital BasedGalenic Labs Helped Combat COVID-19 Shortages A Case Study from Northern Italy

—

by

Vishnu
in

Introduction

During the height of the COVID-19 pandemic, the healthcare infrastructure in many nations was tested to its limits—none more so than in northern Italy. In the face of escalating mortality and urgent shortages of antiseptics and disinfectants, a hospital in the PC area responded with an extraordinary measure: the activation of its galenic laboratory for in-house production. This article explores how localized pharmaceutical manufacturing played a vital role in safeguarding healthcare systems.
Visit https://www.clinvirologyjournal.com/ for more groundbreaking research in this field.

Inside the Galenic Response Summary of Findings

The PC Area, encompassing six hospitals with 700+ beds, experienced a surge in demand for sanitization products during March–May 2020. Faced with depleted industrial supplies, hospital pharmacists initiated internal production of:

  • Alcoholic hand gels and solutions (based on WHO guidelines)
  • Amuchina hand solutions
  • Alcoholic sprays for surface disinfection

Key Outcomes:

  • Weekly output: ~600 bottles (500ml) of hand disinfectant, ~400 bottles of gel.
  • No reported adverse reactions or product recalls.
  • Cost savings compared to industrial counterparts, despite emergency procurement needs.

Overcoming Production Barriers with Innovation

To address severe pandemic-related shortages, the hospital lab took these innovative steps:

  • Repurposed galenic labs to formulate WHO-recommended hand sanitizers.
  • Sourced raw materials such as ethanol, glycerol, hydrogen peroxide, and purified water through rapid procurement networks.
  • Ensured pharmacist safety using personal protective equipment (PPE) and strict quality controls.

The result was a cost-effective and timely supply of essential disinfectants when the commercial market faltered.

Medical Validation and Safety Standard

Production followed European Pharmacopeia (EP) guidelines and WHO formulation protocols:

  • Formulation I: Ethanol 80% v/v, Glycerol 1.45%, Hydrogen Peroxide 0.125%
  • Formulation II: Isopropyl alcohol 75% v/v, Glycerol 1.45%, Hydrogen Peroxide 0.125%

These standards ensured microbial safety, effective disinfection, and high skin tolerance for healthcare workers confirmed by internal monitoring and international literature.

Further Reading

For a deeper dive, read the full research article:
https://doi.org/10.29328/journal.ijcv.1001027

Why This Matters for Future Pandemic Preparedness

This case highlights a scalable model for other advanced and developing nations. Decentralized, hospital-level production ensures:

  • Rapid deployment of disinfectants
  • Reduced dependency on global supply chains
  • Enhanced resilience in public health emergencies

Explore More Research & Share Your Voice

Explore more studies at https://www.clinvirologyjournal.com/ and join the conversation by sharing your thoughts in the comments below!

Disclaimer: This content is generated using AI assistance and should be reviewed for accuracy and compliance before considering this article and its contents as a reference. Any mishaps or grievances raised due to the reusing of this material will not be handled by the author of this article.

Comments

Leave a comment